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Abstract
Background: Tuberculosis, caused by Mycobacterium tuberculosis or Mycobacterium bovis, remains one of the
leading infectious diseases worldwide. The ability of mycobacteria to rapidly grow in host macrophages is a factor
contributing to enhanced virulence of the bacteria and disease progression. Bactericidal functions of phagocytes
are strictly dependent on activation status of these cells, regulated by the infecting agent and cytokines.
Pathogenic mycobacteria can survive the hostile environment of the phagosome through interference with
activation of bactericidal responses. To study the mechanisms employed by highly virulent mycobacteria to
promote their intracellular survival, we investigated modulating effects of two pathogenic M. bovis isolates and a
reference M. tuberculosis H37Rv strain, differing in their ability to multiply in macrophages, on activation phenotypes
of the cells primed with major cytokines regulating proinflammatory macrophage activity.
Results: Bone marrow- derived macrophages obtained from C57BL/6 mice were infected by mycobacteria after a
period of cell incubation with or without treatment with IFN-γ, inducing proinflammatory type-1 macrophages (M1),
or IL-10, inducing anti-inflammatory type-2 cells (M2). Phenotypic profiling of M1 and M2 was then evaluated. The
M. bovis strain MP287/03 was able to grow more efficiently in the untreated macrophages, compared with the
strains B2 or H37Rv. This strain induced weaker secretion of proinflammatory cytokines, coinciding with higher
expression of M2 cell markers, mannose receptor (MR) and arginase-1 (Arg-1). Treatment of macrophages with IFN-γ
and infection by the strains B2 and H37Rv synergistically induced M1 polarization, leading to high levels of
inducible nitric oxide synthase (iNOS) expression, and reduced expression of the Arg-1. In contrast, the cells infected
with the strain MP287/03 expressed high levels of Arg-1 which competed with iNOS for the common substrate
arginine, leading to lower levels of NO production.
Conclusions: The data obtained demonstrated that the strain, characterized by increased growth in macrophages,
down- modulated classical macrophage activation, through induction of an atypical mixed M1/M2 phenotype.
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Background
Macrophages are key cells of innate immunity to differ-
ent mycobacterial infections, including human and bo-
vine tuberculosis caused predominantly by Mycobacterium
tuberculosis (Mtb) and Mycobacterium bovis (Mbv), re-
spectively. The functions of MΦ after infection with myco-
bacteria are strictly dependent on the activation phenotype,
which is determined by bacteria- induced signaling through
the pattern-recognition receptors (PRRs), leading to innate
MΦ activation, and is also regulated by a variety of signals
from the surrounding microenvironment. The most im-
portant of these signals are cytokines produced by activated
lymphocytes and other cells.
Macrophages primed with Th1 cytokine (IFN-γ)
polarize to proinflammatory M1 cells, readily increasing
the level of activation in the presence of microbial
ligands, and developing the phenotype typical of classic-
ally activated macrophages, CAM [1]. These cells pro-
duce large amounts of proinflammatory cytokines and
generate reactive oxygen (ROI) and nitrogen (RNI) inter-
mediates which enhance bactericidal and cytotoxic MΦ
functions. In contrast, macrophages activated with Th2
cytokines (IL-4, IL-13), exposed to immune complexes
in combination with TLR ligands, or IL-10, polarize to
distinct M2 phenotypes, M2a, M2b and M2c, respect-
ively, associated with alternatively activated macrophages
(AAM), which display anti-inflammatory and tissue re-
pair activities [2]. The M2 macrophages are character-
ized by expression of typical markers, including
increased arginase 1 (Arg-1) expression and activity,
increased expression of scavenger and mannose (MR/
CD206) receptors, and production of the anti-
inflammatory cytokine (IL-10), which is more pro-
nounced in the AAM induced by exogenic IL-10. The
MΦ primed by IL-10 were demonstrated to secrete
none, or very low levels, of proinflammatory cytokines
in response to bacterial LPS, but produce anti-
inflammatory IL-10 and TGF-β, that prompted Gordon
to term this M2 state the ‘innate/acquired inactivation’
[1] and include these cells to group of ‘regulatory’ MF
[3]. The cytokines produced by Th1 and Th2 cells
or IL-10 induce extreme phenotypes of MΦ activa-
tion characterized by distinct markers. After infection,
microbial products can modulate MΦ activation
through PRR-dependent signaling, providing a wide
range of MΦ phenotypes between the two extremes
[4].
During acute inflammatory responses to Mtb, macro-
phages are typically polarized to M1 under the effects of
mycobacterial agonists for PRRs and IFN-γ produced by
Th1, and exert potent anti-microbial effects [5]. The
transcriptomic analysis of responses of murine bone
marrow- derived macrophages (BMDM) to Mtb and
IFN-γ revealed an overlap of genes modulated by
mycobacteria and IFN− γ, which corresponded to a M1
profile [6,7]. In contrast, pretreatment of the BMDM
with IL-4 resulted in the M2 transcriptional profile, and
these cells presented delayed, and partially diminished,
anti-mycobacterial responses [7]. These data were
obtained employing the ‘laboratory’ Mtb strain H37Rv,
widely used as a reference virulent strain for studies of
tuberculosis pathogenesis. However, there is mounting
evidence that strains of Mtb and Mbv circulating in
human and animal populations are more genetically and
functionally diverse than previously appreciated, demon-
strating strain-dependent variation in virulence [8-11].
In the model of MΦ infection, highly virulent and epide-
miologically successful strains of Mtb were able to grow
faster than the less virulent isolates [12,13]. The
enhanced bacterial growth was observed not only in the
intact murine MΦ, but also in those primed by IFN-γ
[14,15], suggesting, that at least some virulent strains of
Mtb were able to inhibit CAM. Additionally, highly viru-
lent Mtb were able to switch the initial Th1-type reac-
tion, associated with high levels of IFN-γ production in
the infected mice, to potent Treg cell response leading
to production of IL-10, which reduced the bactericidal
activities of MΦ [11]. In contrast to Mtb, modulating
effects of pathogenic Mbv strains, differing in virulence-
associated properties, on the MΦ activation phenotypes,
determined by main regulating cytokines, IFN-γ and IL-
10, have not been yet elucidated.
In this work, we studied the effects of pathogenic Mbv
isolates and reference Mtb strain H37Rv, differing in
their ability to grow intracellularly in murine MΦ, on
polarization of these cells to M1 and M2 phenotypes
induced by the treatment with IFN-γ and IL-10, respect-
ively. Expression levels of typical M1 and M2 markers
were evaluated. Additionally, we verified intracellular
signaling pathways that could regulate production of
microbicidal RNIs, through the modulation of iNOS and
Arg-1 expression.
Our results demonstrated that the Mbv strain MP287/
03, characterized by increased intracellular survival and
growth, in contrast to other strains, inhibited classical
MΦ activation, switching the M1 activation profile of
the cells, stimulated with IFN-γ, to a mixed M1/M2
phenotype. Increased expression of Arg-1, observed in
these cells, coincided with low levels of nitric oxide pro-
duction, suggesting that reduced exposure of bacteria to
nitrosative stress contributed to increased intracellular
survival of these bacteria.
Results
Pathogenic isolates of M. bovis differed in their capacity
to grow in the cultured macrophages
To investigate the mechanisms employed by pathogenic
Mbv to modulate MΦ activation, we selected for this
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study two clinical isolates of Mbv which showed signifi-
cant difference in capacity of bacteria to grow in MΦ.
As shown in Figure 1A, growth kinetics of one of the
Mbv isolates, strain B2, was similar to that of the refer-
ence Mtb strain H37Rv. In contrast, the Mbv strain
MP287/03 grew in MΦ significantly faster (p < 0.001).
After six days of incubation, an increase in the numbers
of intracellular bacteria was 3-fold higher in cultures
infected by the strain MP287/03, than those infected by
strain B2. In contrast to the intracellular growth, growth
rate of the tested strains in specific Middlebrook 7H9
media was similar, demonstrating that the intrinsic
Figure 1 Evaluation of the growth properties of M. bovis isolates. Isolates obtained from animals with tuberculosis, strains MP287/03 and B2,
and reference M. tuberculosis strain H37Rv, were used for infection of BMDM in vitro (A) or cultured in Middlebrook 7H9 broth (B). Growth rates
of mycobacteria inside M infected at MOI of 1 were determined using the colony count method. Intracellular CFU numbers were quantified
immediately after infection (day 0) or at 3 or 6 days after infection (A). Growth rates of mycobacteria in 7 H9 Middlebrook broth were monitored
by measurement of OD of the mycobacterial cultures by spectrophotometry. The growth curves of the mycobacterial strains within a 12 day
period of incubation are presented. (B). Values are the means ± SD of three independent experiments with samples in triplicate.
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abilities of the different strains to replicate were similar
(Figure 1B). These data suggested that the observed dif-
ferences in intracellular growth of these bacteria could
be associated with differential resistance of the bacterial
strains to microbicidal effects of MΦ.
The main cytokines regulating proinflammatory MΦ
activity, IFN-γ [16] and IL-10 [17], are known to in-
crease or decrease the bactericidal functions of these
cells, respectively. To verify whether intracellular sur-
vival of the different mycobacterial strains are equally
regulated by the effects of IFN-γ and IL-10 on MΦ, we
tested intracellular growth rates of the studied bacterial
strains in BMDM cultured in the presence of these cyto-
kines. As shown in Figure 2, the treatment of macro-
phage cultures with recombinant IL-10 had no
significant effect on the growth of the studied strains.
Treatment with IFN-γ significantly reduced the growth
rate of the strains B2 and H37Rv, but this effect was less
pronounced in the cell cultures infected with the strain
MP287/03. These data demonstrated the resistance of
rapidly growing strain (MP287/03) to the effects of IFN-
γ, which is probably mediated by the ability of the myco-
bacteria to inhibit classic macrophage activation induced
by this cytokine.
Innate macrophage activation by the pathogenic
mycobacterial strains differing in growth kinetics in
macrophages
To study the effects of pathogenic Mbv isolates on MΦ ac-
tivation, we evaluated characteristic markers of M1- and
M2- type macrophage polarization induced in infected
BMDM, in the presence or absence of IFN-γ and IL-10.
First, we investigated the innate MΦ activation
induced by infection. Evaluation of expression of the M1
proinflammatory markers, including factors mediating
recruitment of the phagocytic cells (MCP-1/CCL2 and
MIP-2/CXCL2), and contributing to the MΦ microbicid-
ity (TNF-α, IL-12, IL-6 and NO), demonstrated that the
studied pathogenic mycobacterial strains induced differ-
ent patterns of cytokine secretion by the BMDM
(Figure 3A). Both clinical isolates of Mbv induced less
IL-6 and MCP-1, and, additionally, the Mbv strain
MP287/03 induced less TNF-α, than the reference strain
H37Rv. In contrast, the level of secretion of MIP-2, an
important chemokine regulating migration of granulo-
cytes, was significantly increased in cultures infected
with the Mbv strains. These cells secreted 10-fold more
MIP-2 than the cells infected by H37Rv strain, and 3-
fold more than those infected by the strain B2. Neither
mycobacterial strain tested in this study was able to in-
duce in MΦ the production of NO or IL-12, although
production of these mediators was induced by the LPS
(Figure 3A).
Evaluation of the expression of typical M2 markers
(IL-10, Arg-1 and MR/CD206) by the infected cells
demonstrated that neither strain induced production of
the IL-10 (Figure 3B). In contrast, all the studied myco-
bacterial strains were able to induce expression of Arg-1,
and the highest level was observed in the cells infected
with the strain MP287/03 (Figure 3C). The expression of
MR, which was constitutively high in the intact unin-
fected BMDM, was suppressed by treatment of the cells
with LPS, or infection with the less virulent H37Rv and
B2, whereas the cells infected with the strain MP287/03
continued to express high level of this receptor (Figure 3C).
These data demonstrated that the proinflammatory acti-
vation of MΦ by clinical isolates of Mbv, and particularly
by the fast growing strain MP287/03, was significantly
Figure 2 The capacity of pathogenic mycobacteria to grow intracellularly in macrophages treated with IFN-γ or IL-10. Cultures of BMDM
were pretreated with exogenic murine r-IFN -γ or r-IL-10 for 2 h, infected with the mycobacterial strains at a MOI of 1, as indicated in the legend
to Figure 1, and incubated in the presence of these cytokines for an additional 6 days. The intracellular CFU numbers determined at day 0 and
day 6 are presented. The data of three independent experiments are shown as mean± SD of samples in triplicate. Asterisks represent statistical
significance (p < 0.05) compared to infected cells cultured without addition of the cytokines.
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lower than that induced by the LPS or reference Mtb myco-
bacteria. Additionally, the strain MP287/03 induced in
the MΦ a more pronounced expression of some M2
markers.
However, strong secretion of proinflammatory MIP-2
chemokine observed in cell cultures infected by the strain
MP287/03 suggested that these bacteria induced in MΦ
an atypical, mixed M1/M2 activation phenotype.
Figure 3 The activation profiles of macrophages infected with pathogenic mycobacteria. BMDM were infected with the studied
mycobacterial strains at a MOI of 5:1, washed and incubated for an additional 48 h. The cells left untreated and cells stimulated with LPS
for 48 h were used as a negative and positive controls of proinflammatory activation, respectively. To evaluate markers of M1-type activation (A),
the culture supernatants of infected cultures were harvested and tested for TNF-α, IL-6, MCP-1, MIP-2 and IL-12 by Bioplex test, and for NO
production by Griess reaction. Assays were completed with duplicate samples, and results are expressed as a mean of three independent
experiments. Lines over bars indicate the isolates for which the induced cytokine production differed significantly from that induced by H37Rv
(*p < 0.05; ***p < 0.001). To evaluate markers of M2-type activation, secretion of IL-10 was quantified by Bioplex assay (B), and expression of
Arginase 1 and MR/CD206 in the adhered cells was tested by Western blotting (C). Lower panel, quantification of the protein levels by
densitometric analysis of immunoreactive bands.
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Modulating effects of the pathogenic mycobacterial
strains on the macrophage activation phenotypes
induced by the cell treatment with IFN-γ and IL-10
To study the MΦ activation phenotypes resulted from
combining effects of bacteria and regulating cytokines,
we evaluated expression of the markers of M1
(Figure 4A-4D) and M2 cells (Figure 4E and 4 F), by the
pretreatment of infected BMDM with IFN-γ (Figure 4A),
and IL-10 (Figure 4B). The markers expressed by the
infected cells, which were treated with the cytokines,
were compared with those of the infected cells, which
were left untreated. Treatment with IFN-γ enhanced pro-
duction of proinflammatory mediators in cultures
infected by all the strains studied. However, the levels of
secretion varied in a strain-dependent manner. Macro-
phages infected by the Mbv strains in the presence of
IFN-γ (Figure 4A) secreted significantly less TNF-α, IL-6
and MCP-1, than those infected by the H37Rv strain. In
contrast, production of MIP-2 by the cells infected with
Mbv was significantly higher. As expected, treatment
with IFN-γ induced in the infected MΦ, or those treated
with LPS, production of NO (Figure 4A), which is an im-
portant mediator of MΦ microbicidity, tightly regulated
by the IFN-γ-dependent intracellular pathways. However,
the cells infected with virulent Mbv strain B2, and par-
ticularly by the strain MP287/03, secreted significantly
less NO than those infected with the H37Rv strain.
To verify whether signaling pathways leading to NO
production were differentially modulated by the myco-
bacterial strains, we evaluated induction of iNOS, the es-
sential enzyme for the conversion of arginine to
citrulline and NO. The results obtained showed that
treatment with IFN-γ induced iNOS expression in the
cultured macrophages, and subsequent infection of these
cells with bacteria enhanced the level of enzyme expres-
sion in a similar manner (Figure 4D), demonstrating no
strain-specific difference in the regulation of IFN-γ-
dependent signaling which leads to transactivation of the
iNOS gene.
Evaluation of expression of M2 markers in the cells
pretreated with IFN-γ demonstrated suppression of Arg-
1 expression induced by the strains B2 and H37Rv, but
not those infected with strain MP287/03 (Figure 4E). Ex-
pression of MR by MΦ was slightly inhibited in the cell
cultures treated with IFN-γ, and further reduced after in-
fection of these cells with the strains B2 or H37Rv. In
contrast, infection with the strain MP287/03 restored a
high level of expression of this receptor (Figure 4E), sug-
gesting induction of MR gene transcription due to
mycobacteria in these cells. Neither bacterial strain was
able to induce IL-10 in the cells pretreated with the
IFN-γ (Figure 4F).
To verify the effects of mycobacterial infection on the
IL-10-induced M2 polarization, the cell cultures were
treated with recombinant IL-10. This treatment induced
in the BMDM expression of Arg-1 (Figure 4E) and se-
cretion of IL-10 (Figure 4F) and MCP-1 (Figure 4B). In-
fection of these cells with the mycobacterial strains
promoted expression of M2 markers, further increasing
expression of the Arg-1 and suppressing inhibition of
the MR expression induced by the H37Rv and B2 strains
(Figure 4E). The infected cultures continued to secrete
low levels of IL-10, induced by the exogenic IL-10 pre-
treatment (Figure 4F). Additionally, the treatment of
MΦ with IL-10 suppressed ability of some mycobacterial
strains to induce increased levels of secretion of proin-
flammatory mediators. Significant reduction of secretion
of IL-6 and MCP-1 by MΦ infected with the H37Rv
strain and MIP-2 chemokine secretion, induced by the
strains B2 and MP287/03, was observed (Figure 4B).
These data show that the proinflammatory activities of
MΦ induced by mycobacterial infection were signifi-
cantly inhibited in the cells that were infected after
priming by IL-10. These cells expressed MR and
increased levels of Arg-1, which were particularly high
in the cells infected with MP287/03 strain. Thus, the
treatment with IL-10 favored M2-type activation of the
infected MΦ.
Discussion
In this study, we aimed to investigate the modulating
effects of pathogenic Mbv strains, differing in virulence-
associated properties, on activation phenotypes in MΦ
treated with the main cytokines regulating proinflamma-
tory MΦ activation: IFN-γ and IL-10. Rapid growth of
pathogenic mycobacteria in MΦ is one of the known
factors contributing to bacterial virulence [18,19]. There-
fore, for this work, we selected two Mbv isolates differ-
ing significantly in the capacity to grow in MΦ. One of
these isolates, strain B2, was capable of growing in
BMDM at a rate similar to that of moderately virulent
Mtb strain H37Rv, whereas the intracellular multiplica-
tion of other Mbv strain (MP287/03) was significantly
faster. Additionally, we demonstrated that bacteria of
MP287/03 strain continued to grow rapidly in cells acti-
vated by IFN-γ, whereas the growth of the strains B2
and H37Rv was significantly inhibited under this treat-
ment. These data suggested that the MP287/03 strain
was either more resistant to the bactericidal effects of
macrophages classically activated by IFN-γ, or were able
to inhibit MΦ activation induced by this cytokine.
The modulating effects of the Mbv strains were evalu-
ated in comparison to those of the reference Mtb strain
H37Rv, which was demonstrated in previous studies to
induce in MΦ a proinflammatory activation and syner-
gize with IFN-γ in induction of M1-type polarization of
infected cells [7,20]. In accordance with these observa-
tions, our data demonstrated that the Mtb strain H37Rv
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induced M1 type activation of the infected BMDM, al-
though the level of activation was less pronounced in
comparison with that induced by LPS. Activation of MΦ
by the Mbv strains was even weaker than that induced
by the H37Rv strain. The lowest level of proinflamma-
tory cytokine expression was observed in MΦ infected
with the fast growing Mbv strain MP287/03, although
these cells produced high levels of MIP-2 chemokine.
Additionally, these cells displayed increased levels of ex-
pression of M2 markers (Arg-1 and MR/CD206). Thus,
the MP287/03 mycobacteria induced in MΦ an atypical,
mixed M1/M2 activation phenotype that coincided with
enhanced intracellular growth of the bacteria.
Most important was observation, that this strain
induced weaker production of the key bactericidal fac-
tors, such as TNF-α and NO, even after pretreatment of
MΦ with IFN-γ, priming these cells for M1-type activa-
tion. To study the mechanisms that could underlie the
observed differences in RNI production, we looked at
intracellular signaling pathways leading to NO produc-
tion by the infected cells. The major regulators of NO
production are iNOS and Arg -1, competitive enzymes
which utilize a common substrate (L-arginine) to pro-
duce NO and citrulline, or urea and ornithine, respect-
ively [21]. In previous study [22], induction of Arg-1
expression in MΦ by attenuated Mbv strain BCG was
found to be essential for reduction of NO production,
through the arginine substrate depletion mechanism,
leading to promotion of the intracellular survival of
these mycobacteria.
In this study, we demonstrated that pathogenic Mbv
were also able to induce expression of Arg-1 in the
infected MΦ. Importantly, the fast growing strain
MP287/03 induced higher levels of the Arg-1, than any
other studied strain, and strongly up-regulated expres-
sion of Arg-1 in IFN-γ-treated cells. Although all of the
studied strains enhanced expression of iNOS, induced in
cells by IFN-γ, in a similar manner, the increased level of
Arg-1 observed in MΦ infected with the MP287/03
strain contributed to reduction of NO secretion by these
cells. These data suggested that highly virulent Mbv,
characterized by enhanced growth in MΦ could induce
Arg-1 as a component of the strategy to subvert the
antimicrobial activity of CAM, by hydrolyzing the sub-
strate required for NO production.
Mechanisms leading to induction of Arg-1 expression
by mycobacteria are only recently starting to be eluci-
dated. Autocrine loop of secretion of IL-6, IL-10 and G-
CSF, leading to phosphorylation of STAT3 was deter-
mined as an essential mechanism for induction of Arg-1
expression in BCG-infected MΦ [22]. However, in our
study, the increased Arg-1 expression induced by the
strain MP287/03, coincided with low levels of IL-6 and
IL-10 secretion by the infected MΦ. These data sug-
gested that the signaling pathways, leading to the pro-
nounced induction of the Arg-1 by highly virulent Mbv,
could differ from those induced in the BCG-infected
MΦ and should be investigated further in separate
study.
Another mechanism, underlying the reduced microbi-
cidity of MΦ infected with the strain MP287/03, could
be associated with capacity of these bacteria to induce in
the cells expression of MR. Infection with the strain
H37Rv and incubation with IFN-γ, synergistically inhib-
ited expression of MR gene in murine BMDM [7,23],
constitutively expressing high levels of MR [23], resem-
bling in this manner, alveolar macrophages [24]. In line
with these observations, infection of the cells pretreated
with IFN-γ by the moderately virulent strains, H37Rv
and B2, in our experiments resulted in down-regulation
of MR expression. In contrast to these strains, infection
of MΦ by the strain MP287/03 restored expression of
MR reduced by the IFN-γ treatment. High and persist-
ent levels of MR expression in the MΦ infected with
strain MP287/03 in the presence or absence of IFN-γ
suggested that these cells could be more susceptible to
the deleterious effects of Mannosyl-capped lipoarabino-
mannan (ManLAM) expressed by the pathogenic
(See figure on previous page.)
Figure 4 The activation profiles of macrophages treated with IFN-γ or IL-10 and infected with pathogenic mycobacteria. BMDM were
pretreated, or not, with murine r-IFN-γ or r-IL-10 for 2 h, infected with the studied mycobacterial strains at a MOI of 5:1, washed, treated again
with the cytokines and incubated for an additional 48 h. The cells stimulated with LPS and r-IFN-γ for 48 h, or left untreated, were used as a
positive and negative controls of classical proinflammatory activation, respectively. To evaluate markers of M1-type activation, the culture
supernatants were tested for proinflammatory mediator levels (A-C) and the adhered cells were tested for expression of iNOS (D). Measurement
of TNF-α, IL-6, MCP-1, MIP-2 and IL-12 concentrations was performed by Bioplex test, and NO production was evaluated by Griess reaction Assays
were completed with duplicate samples, and results are expressed as a mean of three independent experiments. To evaluate markers of M2-type
activation, expression of Arginase 1 and MR/CD206 in the adhered cells was tested by Western blotting (E) and secretion of IL-10 was quantified
by Bioplex assay (F). Lower panels in D and E, quantification of the protein levels by densitometric analysis of immunoreactive bands. Asterisks in
A, B and F indicate the infected cultures treated with recombinant IFN-γ or IL-10, for which the induced cytokine production differed significantly
from that in the corresponding cultures incubated without the presence of exogenic cytokines (*p < 0.05; **p < 0.01; ***p < 0.001). Lines over bars
in A and B indicate the Mbv isolates for which the induced cytokine or NO production differed significantly from that induced by H37Rv
(#p < 0.01; ##p < 0.001).
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mycobacteria. Interaction of Man-LAM with MR has
been demonstrated to inhibit fusion of phagosomes with
lysosomes in the infected MΦ, interfere with IFN-γ-
mediated signaling in MΦ activation, as well as suppress
TLR-dependent induction of expression of IL-12 and
other proinflammatory cytokines [25,26]. In line with
this suggestion, the infected cells expressing higher
levels of MR in our experiments were permissive to
enhanced intracellular growth even in the presence of
IFN-γ.
The ability of the strain MP287/03 to induce in MΦ
some properties of the M2 cells, suggested that infection
of the MΦ, pretreated with IL-10, by these bacteria may
synergize in IL-10- dependent M2 polarization of these
cells. The obtained results demonstrated that the treat-
ment with IL-10 led to reduction of the proinflammatory
MΦ activation by the studied mycobacterial strains.
These cells displayed increased expression of the M2
markers, MR, IL-10 and Arg-1. The highest levels of
Arg-1 were observed in the cells infected by MP287/03
mycobacteria, demonstrating that the treatment with IL-
10 favored the M2-type activation of these cells.
Although the cells infected with MP287/03 strain dis-
played increased levels of the M2 markers in the pres-
ence or absence of regulating cytokines, these cells
secreted high levels of the proinflammatory MIP-2 che-
mokine. In contrast to the MCP-1 chemokine, regulating
monocyte recruitment which is essential for formation
of functional granuloma, the continues production of
MIP-2, and other chemokines attracting granulocytes,
was demonstrated to cause excessive recruitment of neu-
trophils to the infected lungs, contributing to tissue
damage in pulmonary tuberculosis, reviewed by [27].
The high level of MIP-2 secretion and inappropriate
proinflammatory MΦ activation, observed in the BMDM
cultures infected with MP287/03 strain in this study,
may have aggravating implications for in vivo infection
with these, fast-replicating intracellular bacteria. Verifi-
cation of this important issue is currently under investi-
gation in our laboratory.
Conclusions
The data obtained in this study show that the pathogenic
Mbv strains differed in their capacity to modulate the M1-
type activation phenotype induced by IFN-γ. In contrast
to the mycobacterial strains demonstrating moderate abil-
ity to grow intracellularly which enhanced classical activa-
tion of MΦ by INF-γ, the fast growing strain of Mbv
induced an atypical, mixed M1/M2 phenotype, leading to
inhibition of MΦ bactericidal activity. These data demon-
strate functional diversity of Mbv strains circulating in
animal population, highlighting novel strategies of intra-
cellular adaptation of the pathogenic mycobacteria.
Elucidating the functional significance of diversity of
virulence-associated properties of Mbv is important for
understanding the diverse outcomes of infection and
mechanisms of pathogenesis of bovine tuberculosis.
Methods
Mycobacteria
Two isolates of Mbv from animals with tuberculosis
were used in this study. The strain B2 was isolated from
buffalo and gently provided by Dr. Eliana Roxo (Bio-
logical Institute, USP, São Paulo, Brazil). The bovine
strain MP287/03 was kindly provided by Dr. José Soares
Ferreira Neto (Institute for Veterinary Medicine, USP,
São Paulo, Brazil). M. tuberculosis strain H37Rv (ATCC)
was kindly provided by Dr. Philip Suffys (Oswaldo Cruz
Foundation, FIOCRUZ, Rio de Janeiro, Brazil).
Mycobacterial strains were grown in suspension in
complete 7H9 Middlebrook broth (Difco, Detroit, MI),
containing 10% albumin dextrose complex, ADC (BD,
Sparks, MD), 0.5% glycerol and 0.05% Tween-80 at 37°C
under Biosecurity level 3 containment conditions. Add-
itionally, sodium pyruvate 0.4% was added to the cul-
tures of Mbv. Bacterial cultures were grown to mid-
logarithmic phase, aliquoted, and stored at −70°C. Before
experiments, the aliquots were thawed, resuspended in
complete 7H9 medium and cultured for 5 days. Bacterial
suspensions were ultrasonicated in water bath to disrupt
small clumps and obtain single cell suspensions. The
resulted dispersion of bacteria was tested by microscopic
examination of the suspension samples stained by the
acid-fast staining procedure. The densities of the suspen-
sions were measured by spectrophotometry, and corre-
sponding concentrations were determined by serial
dilution plating of each strain on Middlebrook 7H10
agar (Difco, Detroit, MI) plates supplemented with 0.5%
glycerol, 10% oleic acid–albumin-dextrose–catalase en-
richment, OADC (BD, Sparks, MD), and, additionally,
with 0.4% sodium pyruvate in the case of Mbv cultures.
After 21 days, total CFU were determined.
Quantification of mycobacterial growth in 7 H9 broth
The bacterial capacity to grow in 7H9 broth was measured
by spectrophotometry. Bacterial suspensions adjusted to
OD600= 0.1 were cultured at 37°C for twelve days with daily
agitation. Bacterial tubes were then vortexed, ultrasonicated
in a water bath, and the OD of suspension was measured.
To confirm the lack of significant alteration in OD600 read-
ings, colony forming units (CFU) were determined for each
culture on day 0 through the plating of appropriate bacter-
ial dilution onto the 7H10 agar.
Generation of bone marrow- derived macrophages
Bone marrow- derived macrophages (BMDM) were
obtained as previously described [28] with some modifi-
cations. Briefly, bone marrow cells were flushed from
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the femur of eight- to ten- week-old specific pathogen-
free C57BL/6 mice. The cells were dispersed in Dulbecco’s
modified Eagle’s medium, DMEM (Sigma, St Louis, MO),
supplemented with 1 mM sodium pyruvate, 2 mM L-glu-
tamine, 0.05 M 2-mercaptoethanol (Gibco BRL, Grand
Island, NY), 10% heat-inactivated FBS (Hyclone, Road
Logan, UT), 50 μg/ml gentamicin (Gibco BRL, Grand
Island, NY), and cultured at 37°C in 5% CO2 atmosphere.
Nonadherent cells were collected after 18 h, resuspended in
the complete DMEM, supplemented with 20%L929 cell-
conditioned medium as a source of M-CSF, and cultured
for 7 days, replacing the medium on day 3. The monolayer
cells were scraped, resuspended in DMEM, supplemented
with 2% FBS, without antibiotics, and plated at a concentra-
tion of 5 x 105 cell/ml in a 96-well plates, 100 μl/well.
Treatment with cytokines and infection of cell cultures
The BMDM cultures were incubated overnight, pre-
treated, or not, with murine recombinant IFN-γ, 100 U/ml
(Bioscience, Camarillo, CA), or IL-10, 20 ηg/ml (Bioscience,
Camarillo, CA) for 2 h, and infected with single-cell suspen-
sions of mycobacterial strains at MOI 1:1 and 5:1. After 3 h
of incubation at 37°C, infected monolayers were washed
and incubated for additional 6 d in new aliquots of culture
medium. In the pretreated cultures, the cytokines were
renewed and were present throughout the incubation
period. Cell viability of infected MΦ was monitored by try-
pan blue exclusion and was over 90% in all experiments.
Quantification of mycobacterial growth in macrophages
Mycobacterial ability to grow intracellularly was evalu-
ated by colony-forming units (CFU) test in the MΦ cul-
tures infected at a MOI of 1:1. After 0, 3 and 6 d of
incubation, cells were lysed with 1% saponin to release
intracellular bacteria. Lysates of infected cells were
resuspended, transferred into screw caps, vortexed and
sonicated in a preheated waterbath sonicator (Unique
800, Brazil) at 37°C for 2 min. Aliquots of the sonicate
were diluted 10-fold in PBS, plated in quadriplicates on
7 H10 agar plates and incubated at 37°C for 21 days.
Cytokine quantification
To study cytokines secreted by infected MΦ, the cell
cultures were infected at a MOI 5:1 in the presence or
absence of recombinant IFN-γ and IL-10, as indicated
above. The infected monolayers were washed and incu-
bated for additional 48 h. After incubation, the culture
supernatants were collected, filtered through 0.22 μm
Spin-X centrifuge tube filters (Corning, NY), and the
supernatant aliquots were stocked at −70°C for posterior
cytokine determination. The cells left untreated and cells
stimulated with LPS of Escherichia coli 011B (Sigma
Aldrich, MO), 1 μg/ml, and r-IFN-γ for 48 h were used
as a negative and positive control of proinflammatory
macrophage activation, respectively. The frozen samples
of culture supernatants of the infected BMDM were
then thawed and immediately analyzed using Bio-Plex
Pro Mouse Cytokine Assay (BioRad Laboratories,
Hercules, CA), following the manufacturers protocol.
Standard curves for each cytokine were generated using
reference cytokine concentrations supplied by the
manufacturer.
Nitric oxide determination
Nitric oxide (NO) generation in the culture supernatants
was assessed by the Griess method to measure nitrites,
which are stable breakdown products of NO. Briefly, cul-
ture supernatant was incubated with the Griess reagents
I (1% sulfanilamide in 2.5% phosphoric acid) and II
(0.1% naphthylenediamine in 2.5% phosphoric acid). The
absorbency was read within 5 min at 550 nm and actual
concentration calculated using a standard curve with
serial dilutions of sodium nitrite.
Detection of iNOS, ARG-1 and MR by Western blot
The infected adherent cells were resuspended in lysis
buffer (10% SDS, 20% glycerol, 5% 2-mercaptoethanol,
2% bromphenol blue and 1 M Tris HCl, pH 6.8) for
western blotting analysis. Cell samples in the lysis buffer
were harvested and equal amounts of proteins were elec-
trophoresed in a 10% or 8% sodium SDS-PAGE gel
under nonreducing conditions. The proteins were then
transferred to nitrocellulose membrane (Amersham
Hybond-ECL GE) using standard procedures. After over-
night blocking with 0.5% non-fatty milk in PBS, the blots
were incubated for 1 hr at room temperature with Ab
against iNOS, 1:1000 (Santa Cruz Biotechnology, CA),
Arg-1, 1:1000 (BD Bioscience), or MR/CD206, 1:100
(Santa Cruz Biotechnology, CA), dissolved in 0.5% non-
fatty milk in PBS. The blots were then washed and incu-
bated with peroxidase-conjugated secondary Ab, 1:8000,
for 1 hr at room temperature, and the resulting mem-
branes were developed using diaminobenzidine/H2O2 as
a substrate for peroxidase. Densitometric analysis of the
protein bands was performed using the software ImageJ
for Windows (NIH, Bethesda, MD). The value for the
control condition (untreated cells) was set as 1 and other
conditions were recalculated correspondingly to allow
ratio comparisons.
Statistical analysis
Statistical analysis was performed using the unpaired
Student’s t test, one-way analysis of variance (ANOVA)
and Bonferroni procedure for multiple range tests,
employing Prism 4 software (GraphPad, San Diego, CA)
to assess statistical significance between groups of data
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defining different error probabilities. A value of p < 0.05
was considered to be significant.
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